SCHEMBL17034951

SCHEMBL17034951

c1ccc(-c2ccc3c(c2)nc(-c2cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c2)c2ccc4ccccc4c23)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ATM Q13315 2/20 0.42
DHFR P00374 1/20 0.40
WHR1 P49842 1/20 0.39
MAPT P10636 7/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 5/20 0.39
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
HTT P42858 2/20 0.39
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39
RECQL P46063 1/20 0.38
KDM4E B2RXH2 4/20 0.36
POLB P06746 1/20 0.36
HSP90AA1 P07900 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17035072 0.96 MEN1 (0.46) MEN1KMT2AATMDHFRWHR1
SCHEMBL18200509 0.95 MEN1 (0.47) MEN1KMT2AATMMAPTALDH1A1
SCHEMBL18200825 0.94 MEN1 (0.49) MEN1KMT2AATMWHR1MAPT
SCHEMBL18200882 0.93 MEN1 (0.44) MEN1KMT2AATMWHR1MAPT
SCHEMBL17035068 0.93 MEN1 (0.48) MEN1KMT2AATMDHFRWHR1
SCHEMBL18200734 0.93 MEN1 (0.43) MEN1KMT2AATMWHR1MAPT
SCHEMBL17034945 0.93 PTGES (0.41) MEN1KMT2AATMDHFRWHR1
SCHEMBL17035061 0.92 MEN1 (0.45) MEN1KMT2AATMDHFRWHR1
SCHEMBL18200482 0.92 MEN1 (0.50) MEN1KMT2AATMWHR1MAPT
SCHEMBL17035030 0.92 MEN1 (0.49) MEN1KMT2AATMDHFRWHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243895-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MEN1 476/4885KMT2A 2092/4885ATM 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.